Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,609.50
Bid: 1,608.50
Ask: 1,609.50
Change: -157.00 (-8.89%)
Spread: 1.00 (0.062%)
Open: 1,616.50
High: 1,620.00
Low: 1,589.50
Prev. Close: 1,766.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Sachs Cuts Vodafone To Neutral

Thu, 15th May 2014 09:05

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
TRADERS: GOLDMAN CUTS VODAFONE TO 'NEUTRAL' ('BUY')
----------
UBS CUTS VODAFONE PRICE TARGET TO 255 (275) PENCE - 'BUY'
----------
CITIGROUP RAISES AB FOODS PRICE TARGET TO 3100 (3000) PENCE - 'NEUTRAL'
----------
TRADERS: BERNSTEIN CUTS ROLLS-ROYCE TO 'UNDERPERFORM' ('MARKET-PERFORM')
----------
UBS RAISES BUNZL PRICE TARGET TO 1650 (1390) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE CUTS ANGLO AMERICAN TO 'NEUTRAL' - TARGET 1850 PENCE
----------
NUMIS RAISES COMPASS GROUP PRICE TARGET TO 975 (900) PENCE - 'HOLD'
----------
GOLDMAN RAISES COMPASS GROUP PRICE TARGET TO 895 (870) PENCE - 'NEUTRAL'
----------
UBS RAISES COMPASS GROUP PRICE TARGET TO 1000 (920) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES COMPASS GROUP PRICE TARGET TO 1022 PENCE - 'EQUAL-WEIGHT'
----------
CITIGROUP RAISES COMPASS GROUP PRICE TARGET TO 1000 (930) PENCE - 'NEUTRAL'
----------
TRADERS: MS STARTS GLAXOSMITHKLINE WITH 'OVERWEIGHT' - PRICE TARGET 1950 PENCE
----------
BERENBERG INITIATES MARKS & SPENCER WITH 'HOLD' - TARGET 415 PENCE
----------
BERENBERG INITIATES NEXT WITH 'BUY' - TARGET 7740 PENCE
----------
CITIGROUP CUTS ITV PRICE TARGET TO 175 (191) PENCE - 'SELL'
----------
JPMORGAN RAISES ITV PRICE TARGET TO 232 (229) PENCE - 'OVERWEIGHT'
----------
GOLDMAN RAISES BRITISH LAND PRICE TARGET TO 785 (763) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES BRITISH LAND PRICE TARGET TO 760 PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS CENTRICA PRICE TARGET TO 359 (377) PENCE - 'BUY'
----------
NUMIS RAISES LONDON STOCK EXCHANGE TO 'ADD' ('HOLD') - TARGET 2010 (1881) PENCE
----------
FTSE 250
----------
CANACCORD CUTS INFORMA PRICE TARGET TO 535 (568) PENCE - 'HOLD'
----------
UBS CUTS DRAX GROUP PRICE TARGET TO 790 (920) PENCE - 'BUY'
----------
UBS CUTS ICAP PRICE TARGET TO 330 (340) PENCE - 'SELL'
----------
CITIGROUP RAISES TAYLOR WIMPEY PRICE TARGET TO 135 (131) PENCE - 'BUY'
----------
UBS RAISES TAYLOR WIMPEY PRICE TARGET TO 156 (150) PENCE - 'BUY'
----------
BERENBERG INITIATES DEBENHAMS WITH 'HOLD' - TARGET 87 PENCE
----------
BERENBERG INITIATES SUPERGROUP WITH 'BUY' - TARGET 1490 PENCE
----------
CITIGROUP CUTS LONMIN TO 'NEUTRAL' ('BUY') - TARGET 277 (443) PENCE
----------
GOLDMAN RAISES JOHN WOOD PRICE TARGET TO 800 (770) PENCE - 'BUY'
----------
CANACCORD CUTS CATLIN GROUP PRICE TARGET TO 555 (600) PENCE - 'BUY'
----------
NUMIS RAISES CATLIN GROUP TO 'ADD' ('HOLD') - TARGET 585 PENCE
----------
Numis Upgrades Kier To Buy, Retains 2,125p Target
----------
MAIN MARKET AND AIM
----------
BERENBERG INITIATES ASOS WITH 'BUY' - TARGET 5350 PENCE
----------
CITIGROUP RAISES MARSHALLS GROUP PRICE TARGET TO 195 (190) PENCE - 'NEUTRAL'
----------
BERENBERG INITIATES ASOS WITH 'BUY' - TARGET 5350 PENCE
----------
LIBERUM RAISES STAFFLINE PRICE TARGET TO 966 (630) PENCE - 'BUY'
----------
CANACCORD RAISES CHIME COMMUNICATIONS PRICE TARGET TO 390 (383) PENCE - 'BUY'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.